Edap Tms (EDAP) to Release Quarterly Earnings on Thursday

Edap Tms (NASDAQ:EDAP - Get Free Report) will be posting its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Edap Tms to post earnings of ($0.16) per share for the quarter. Persons interested in listening to the company's earnings conference call can do so using this link.

Edap Tms (NASDAQ:EDAP - Get Free Report) last released its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.04). Edap Tms had a negative return on equity of 36.41% and a negative net margin of 31.68%. The firm had revenue of $16.97 million during the quarter, compared to analysts' expectations of $17.16 million. On average, analysts expect Edap Tms to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Edap Tms Trading Down 3.0 %

Shares of EDAP stock traded down $0.09 during mid-day trading on Thursday, hitting $2.90. 64,788 shares of the company's stock were exchanged, compared to its average volume of 46,164. The stock has a market cap of $107.60 million, a price-to-earnings ratio of -5.54 and a beta of 0.40. The stock has a 50-day simple moving average of $2.97 and a two-hundred day simple moving average of $4.71. Edap Tms has a fifty-two week low of $2.27 and a fifty-two week high of $8.50. The company has a quick ratio of 1.80, a current ratio of 2.45 and a debt-to-equity ratio of 0.03.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. StockNews.com raised shares of Edap Tms from a "sell" rating to a "hold" rating in a research report on Wednesday, September 25th. HC Wainwright reissued a "buy" rating and issued a $19.00 target price on shares of Edap Tms in a research note on Thursday, August 29th.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.